Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease

Pediatric Cardiology

Volumn 31, Issue 5, 2010, Pages 657-662

  Smadja, David M ^a,b,c   Gaussem, Pascale ^a,b,c   Mauge, Laetitia ^a,b,c   Lacroix, Romaric ^d   Gandrille, Sophie ^a,b,c   Remones, Véronique ^c   Peyrard, Séverine ^b,c   Sabatier, Florence ^d   Bonnet, Damien ^a,e   Lévy, Marilyne ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Circulating endothelial cells; Congenital heart disease; Endothelial damage; Endothelial microparticles; Pulmonary hypertension

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL PROTEIN C RECEPTOR; INTERLEUKIN 6; PLACENTAL GROWTH FACTOR; PROCOAGULANT; THROMBOMODULIN; VASCULOTROPIN; BIOLOGICAL MARKER;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL DAMAGE; CELL REGENERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HUMAN; LUNG ARTERY PRESSURE; PREDICTOR VARIABLE; PULMONARY HYPERTENSION; AGE; BLOOD; CHILD; COMPLICATION; CONGENITAL HEART MALFORMATION; FEMALE; HYPERTENSION, PULMONARY; INFANT; MALE; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

AGE FACTORS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE;

EID: 77955095254     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9674-0     Document Type: Article

References (33)

1. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16:3381-3388.
2. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y (2008) Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 177:1268-1275.
3. Autiero M, Luttun A, Tjwa M, Carmeliet P (2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1:1356-1370.
4. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A, Desprez D, Chabot F, Weitzenblum E, Freyssinet JM, Chaouat A, Toti F (2008) Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177:536-543.
5. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, Haubitz M, Hebbel RP, Lip GY, Mancuso P, Sampol J, Solovey A, Dignat-George F (2005) Circulating endothelial cells: biomarker of vascular disease. Thromb Haemost 93:228-235. (Pubitemid 40253726)
6. Boos CJ, Blann AD, Lip GY (2007) Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. Methods Mol Med 139:211-224.
7. Boos CJ, Balakrishnan B, Blann AD, Lip GY (2008) The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis. J Thromb Haemost 6:1841-1850.
8. Boulanger CM, Amabile N, Tedgui A (2006) Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48:180-186.
9. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, Geraci MW, Voelkel NF (2003) Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 90:698-703.
10. Cella G, Bellotto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226-1230. (Pubitemid 32960098)
11. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A (2009) Endothelial microparticles in diseases. Cell Tissue Res 335:143-151.
12. Furstenberger G, von Moos R, Lucas R, Thurlimann B, Senn HJ, Hamacher J, Boneberg EM (2006) Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 94:524-531.
13. Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, Zeiher AM (2004) Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291:435-441.
14. Humbert M, Montani D, Perros F, Dorfmuller P, Adnot S, Eddahibi S (2008) Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vasc Pharmacol 49:113-118.
15. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, RabinovitchM(2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S-24S. (Pubitemid 38759713)
16. Kimura H, Okada O, Tanabe N, Tanaka Y, Terai M, Takiguchi Y, Masuda M, Nakajima N, Hiroshima K, Inadera H, Matsushima K, Kuriyama T (2001) Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 164:319-324.
17. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, Simoons ML, Boersma E (2006) Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 47:307-311.
18. Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM (2008) CD40 ligand ? microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 52:1302-1311.
19. Levy M, Maurey C, Celermajer DS, Vouhe PR, Danel C, Bonnet D, Israel-Biet D (2007) Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J Am Coll Cardiol 49:803-810. (Pubitemid 46240714)
20. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831-840.
21. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
22. Mancuso P, Colleoni M, Calleri A, Orlando L, Maisonneuve P, Pruneri G, Agliano A, Goldhirsch A, Shaked Y, Kerbel RS, Bertolini F (2006) Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 108:452-459.
23. McLaughlin VV, McGoon MD (2006) Pulmonary arterial hypertension. Circulation 114:1417-1431.
24. Menashi S, Aurousseau MH, Gozin D, Daffos F, D'Angelo A, Forestier F, Boffa MC (1999) High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 81:906-909.
25. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594-2604.
26. Proulle V, Hugel B, Guillet B, Grunebaum L, Lambert T, Freyssinet JM, Dreyfus M (2005) Circulating microparticles are elevated in haemophiliacs and nonhaemophilic individuals aged\18 years. Br J Haematol 131:487-489.
27. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F (2009) Circulating endothelial cells, microparticles, and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 13:454-471.
28. Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Satoh T, Nakanishi N (2000) Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation 102:2720-2725.
29. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S (2007) Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176:.
30. Saposnik B, Lesteven E, Lokajczyk A, Esmon CT, Aiach M, Gandrille S (2008) Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma. Blood 111:3442-3451.
31. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S-12S.
32. Smadja DM, Gaussem P, Mauge L, Israel-Biet D, Dignat-George F, Peyrard S, Agnoletti G, Vouhe PR, Bonnet D, Levy M (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119:374-381.
33. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G (2006) Circulating CD31?/annexin V? apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26:112-116. (Pubitemid 43732236)